PubMed

Nasopharyngeal carcinoma: molecular biomarker discovery and progress.

Cho WC.

Mol Cancer. 2007 Jan 2;6:1. Review.PMID: 17199893 [PubMed - indexed for MEDLINE]Related articlesFree article

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments.

Tao Q, Chan AT.

Expert Rev Mol Med. 2007 May 4;9(12):1-24. Review.PMID: 17477889 [PubMed - indexed for MEDLINE]Related articles

The enigmatic epidemiology of nasopharyngeal carcinoma.

Chang ET, Adami HO.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1765-77. Review.PMID: 17035381 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.

Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, Xiao L, Huang D, Li Z, Li D, Wu M, Li X, Shen S, Wang R, Cao L, Tang K, Li G.

Acta Biochim Biophys Sin (Shanghai). 2009 May;41(5):414-28.PMID: 19430707 [PubMed - indexed for MEDLINE]Related articlesFree article

Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.

Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, Luo DZ, Mo WG, Fukui Y, Kawanishi S.

Int J Cancer. 2008 Jun 1;122(11):2517-25.PMID: 18307254 [PubMed - indexed for MEDLINE]Related articles

Aetiology of nasopharyngeal carcinoma. A review.

Kumar S, Mahanta J.

Indian J Cancer. 1998 Jun;35(2):47-56. Review.PMID: 9849024 [PubMed - indexed for MEDLINE]Related articles

Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China.

Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, Xie S, Liu Q, Liu T, Huang J, Xie W, Li Z, Zhao Y, Wang E, Marincola FM, Yao K.

J Transl Med. 2008 Jun 20;6:32.PMID: 18570662 [PubMed - indexed for MEDLINE]Related articlesFree article

Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions.

Ma BB, Hui EP, Chan AT.

Cancer Sci. 2008 Jul;99(7):1311-8. Epub 2008 May 21. Review.PMID: 18498420 [PubMed - indexed for MEDLINE]Related articles

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.

Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX.

Cancer Biol Ther. 2007 Dec;6(12):1997-2004. Epub 2007 Oct 13.PMID: 18087217 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation.

Chen X, Liang S, Zheng W, Liao Z, Shang T, Ma W.

BMC Genomics. 2008 Jul 7;9:322.PMID: 18605998 [PubMed - indexed for MEDLINE]Related articlesFree article

Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma.

Masmoudi A, Toumi N, Khanfir A, Kallel-Slimi L, Daoud J, Karray H, Frikha M.

Cancer Treat Rev. 2007 Oct;33(6):499-505. Epub 2007 Jun 4. Review.PMID: 17544585 [PubMed - indexed for MEDLINE]Related articles

Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.

Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.

Chin Med J (Engl). 2009 May 20;122(10):1173-8.PMID: 19493466 [PubMed - indexed for MEDLINE]Related articlesFree article

Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.

Ma BB, Chan AT.

Expert Rev Anticancer Ther. 2006 Mar;6(3):383-94. Review.PMID: 16503855 [PubMed - indexed for MEDLINE]Related articles

Aetiology of nasopharyngeal carcinoma.

Chan SH.

Ann Acad Med Singapore. 1990 Mar;19(2):201-7. Review.PMID: 2189340 [PubMed - indexed for MEDLINE]Related articles

Nasopharyngeal carcinoma: the role of the Epstein-Barr virus.

Chu EA, Wu JM, Tunkel DE, Ishman SL.

Medscape J Med. 2008 Jul 16;10(7):165.PMID: 18769688 [PubMed - indexed for MEDLINE]Related articlesFree article

Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.

See HS, Yap YY, Yip WK, Seow HF.

World J Surg Oncol. 2008 Feb 15;6:18.PMID: 18275617 [PubMed - indexed for MEDLINE]Related articlesFree article

Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.

Niemhom S, Kitazawa S, Kitazawa R, Maeda S, Leopairat J.

Cancer Detect Prev. 2008;32(2):127-34. Epub 2008 Jul 15.PMID: 18632221 [PubMed - indexed for MEDLINE]Related articles

Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.

O'Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB, Arrand JR, Dawson CW, Young LS.

J Gen Virol. 2008 Nov;89(Pt 11):2833-42.PMID: 18931081 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of Epstein-Barr-virus-encoded small nuclear RNA in nasopharyngeal carcinomas of Aegean Turkish patients.

Ertan Y, Hekimgil M, Karaarslan S, Soydan S.

Virchows Arch. 2008 Apr;452(4):411-4. Epub 2008 Feb 26.PMID: 18299891 [PubMed - indexed for MEDLINE]Related articles

Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma.

Chan CM, Wong SC, Lam MY, Hui EP, Chan JK, Lo ES, Cheuk W, Wong MC, Tsao SW, Chan AT.

Arch Pathol Lab Med. 2008 Apr;132(4):675-83.PMID: 18384219 [PubMed - indexed for MEDLINE]Related articles